by Jennifer Merschdorf, YSC CEO | Nov 19, 2014
When a young woman is diagnosed with breast cancer, she has many questions and feelings of uncertainty. When I was diagnosed in 2010 at the age of 36, I felt so alone. Yes, I had support from my husband, family and friends, but I longed to meet other young women who...
by Megan McCann, YSC Director of Programs | Nov 4, 2014
Once you hit the mark of being cancer free for five or more years, you may feel some sense of relief. But, you may also feel uncertainty or anxiety around your future. Why are those treatment effects still lingering? Will I ever feel the same as I did before breast...
by Pablo Colon, YSC Board Member & 'I RIDE 4 HER' TdP Co-Captain | Oct 17, 2014
Breast cancer not only impacts the patient, but also the co-survivors (partners, spouses, siblings, parents and friends). In addition to the 12 profiles of young women affected by breast cancer, we also wanted to share the true impact of breast cancer from a...
by Jennifer Merschdorf, YSC CEO | Oct 10, 2014
As a young survivor, you know that Young Survival Coalition (YSC) is here for you from the day of your breast cancer diagnosis through treatment and into survivorship. YSC is also here for you when it’s time to celebrate life! Do you ever feel the need to just “Shake...
by Jean Rowe, LCSW, OSW-C, CJT, Director of Support & Provider Engagement | Oct 8, 2014
Recently, YSC received the exciting news that we have been awarded a $1.75 million grant to be used during the next five years. This generous funding will enhance the support services for young women diagnosed with breast cancer. YSC was one of only seven...
by Jennifer Merschdorf, YSC CEO | Sep 30, 2014
If October makes you cringe a bit, you aren’t alone. For many survivors and co-survivors, October’s breast cancer awareness campaigns are a constant reminder of what you have been through and may still be going through. We call it the “collateral damage” of breast...
by Amanda Buss-Sivak, Guest Blogger | Sep 3, 2014
Amanda is an 8-year cancer thriver from Pennsylvania now living with metastatic disease. We asked her to share a little about her journey and what has helped her along the way. Amanda will be writing a quarterly blog for YSC. In 2006, at the age of 28, when I laid...
by Michelle Esser, YSC Senior Program Manager, Research and Advocacy | Jul 30, 2014
Although you may not have heard it on the news, a piece of legislation important to young women generally and to young women diagnosed with breast cancer in particular was introduced last week. On July 24, Representatives Debbie Wasserman Schultz (D-FL) and Renee...
by | Jul 8, 2014
Many young women who are diagnosed with breast cancer feel alone. Even for those with supportive families and friends, there’s sometimes a longing to connect with women who “get it.” To help alleviate this isolation, Young Survival Coalition will host the 2015...
by Tracy Leduc, Breast Cancer Survivor, Research Think Tank Advocate | Jun 12, 2014
Last December, a friend of mine who shares my interest in breast cancer research suggested that I apply for the Scientist – Survivor Program (SSP) at the annual conference of the American Association for Cancer Research (AACR). Having been through treatment for...
by Diana Chingos, Young Survivor, YSC Research Think Tank Advocate | Jun 1, 2014
Each year, new cancer-related study results and data are released at the ASCO (American Society of Clinical Oncology) annual meeting held in Chicago. Today at ASCO 2014, long-awaited data from the SOFT and TEXT trials was released and these results may impact the...
by | May 23, 2014
Young Survival Coalition’s SurvivorLink peer mentoring program has helped thousands of young breast cancer survivors by connecting them with trained volunteers who’ve been through similar situations. SurvivorLink Volunteer mentors are women from all backgrounds who...
by Joy Simha, YSC Co-Founder | Apr 29, 2014
BioMarin, a biopharmaceutical company, is launching a clinical trial to evaluate BMN 673, a potential first best-in-class PARP (poly ADP-ribose polymerase) inhibitor. This inhibitor is for patients with hereditary forms of breast cancer, specifically deleterious gBRCA...
by Michelle Esser, YSC Senior Program Manager, Research and Advocacy | Apr 9, 2014
YSC wants to keep our constituents updated on relevant medical news, and we have three breast cancer updates to share. They include: (1) FDA approval of Perjeta before surgery in HER2+ breast cancer; (2) the PALOMA study that includes young women in the study of a...
